You just read:

Addition of obinutuzumab (GA101) or rituximab to chlorambucil Improves Outcomes for Elderly Patients With Chronic Lymphocytic Leukemia (CLL) and Co-Existing Medical Conditions (Comorbidities)

News provided by

European Hematology Association

14 Jun, 2013, 07:30 BST